Home Nostos Genomics

Nostos Genomics

In operation
Seed Round Financing
Disease Identification Platform Developer

Basic Information

Nostos Genomics GmbH Collaborates with Genetic Testing Labs to Provide Clear and Rapid Diagnoses for More Individuals with Genetic Disorders. To Achieve This, We Have Developed a Platform That Leverages a Unique Combination of Machine Learning and Synthetic Biology. The Company’s Disease Identification Platform, AION, Can Identify Genetic Variants Responsible for Over 10,000 Diseases, Reducing Diagnostic Time from an Average of 12 Hours to Within Two Minutes.
Nostos Genomics GmbH
Berlin,Berlin,Germany
less than 15 people
January 01, 2018
--